One Agency ActThis bill consolidates federal antitrust enforcement authority in one department by transferring the Federal Trade Commission's (FTC) antitrust functions, employees, assets, and funding to the Department of Justice (DOJ).The bill provides a one-year period for DOJ to implement the transition and allows DOJ to extend the period once for an additional 180 days. During the transition period, DOJ may restructure the department's antitrust division and deputize FTC antitrust employees to investigate and prosecute antitrust violations on behalf of DOJ prior to the completion of the transfer of personnel from the FTC to DOJ.DOJ is also authorized to require businesses to file annual or special reports about the business’s organization, conduct, practices, management, and relationship to other businesses filing such reports.
SAFE Act Save Americans from the Fentanyl Emergency Act
Quality Defense Act of 2025 Providing a Quality Defense Act of 2025
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the bill establishes a new, alternative registration process for certain schedule I research.The bill also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of the Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
NCAA Accountability Act of 2025
Radiation Exposure Compensation Reauthorization Act Radiation Exposure Compensation Act Amendments of 2025 Radiation Exposure Compensation Expansion Act
AMERICA Act Advertising Middlemen Endangering Rigorous Internet Competition Accountability Act